Donglu Tab.
Indication(s): Non-insulin dependent diabetes mellitus（ICD-9：250）
Main Ingredient(s): Glimepiride
Ingredient Dosage: 2 mg / 4 mg
NHI code: Ac47258100 / AC52113100
Packaging: PTP 900 pieces per case
Manufacturer: Root Chemical Pharmaceutical Co., Ltd.
It is the next-generation SU Receptor hypoglycemic drug.
★ It is the next-generation SU Receptor hypoglycemic drug, so the chances of occurrence of hypoglycemia side effects are the lowest.
★ It possesses high dosage which lowers mental stress of taking medicine so many times for patients and increases patient compliance.
★ Long-term usage. One dose per day. Can be taken along with other drugs. Convenient to take.
★ It improves insulin resistance and decreases occurrence of proteinuria.